Anti-HAV IgM Rapid Test Kit

In human serum, plasma, and whole blood samples, the test kit is designed for the qualitative identification of IgM antibodies specific to the Hepatitis A virus (HAV).

It is intended for the qualitative analysis of specific antibodies to the Hepatitis B surface (HBs) in samples of whole blood, serum, and plasma from humans.

A test kit has been developed to identify the presence of HCV-specific antibodies in human serum, plasma, and whole blood samples.

A simple point-of-care test called a test kit makes it possible to qualitatively screen for syphilis in samples of human serum, plasma, and whole blood.

The purpose of the test kit is to identify HBsAg in human serum, plasma, and whole blood samples in a qualitative manner.

The test kit is made to identify anti-HIV antibodies and HBsAg in human serum, plasma, and whole blood samples in a qualitative manner.

It is made to identify Human Immunodeficiency Virus (HIV) antigens and HIV-specific antibodies in human serum, plasma, and whole blood samples in a qualitative and discriminating manner.

It is made to identify Human Immunodeficiency Virus (HIV) antigens and HIV-specific antibodies in human serum, plasma, and whole blood samples in a qualitative and discriminating manner.

It is intended for the qualitative and selective detection of Human Immunodeficiency Virus (HIV) antigens and antibodies in human serum, plasma, and whole blood samples.

The test kit is intended to identify IgM antibodies against the Hepatitis A virus (HAV) in human serum, plasma, and whole blood samples.

The HBsAg, HCV, HIV, and TP antigens may be qualitatively detected and distinguished with this test kit in human serum, plasma, and whole blood samples.

The test kit is intended for the qualitative identification of Neisseria gonorrhoeae antigens in urine or vaginal swabs.